THYROFIX 75 micrograms, tablet 30 tablets
Active ingredients: Levothyroxine sodium, Levothyroxine sodium
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THYROFIX 75 microgrammes, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC TE (thermo-élastique) PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES (GRECE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Dec 2017
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64826590CIP73001379CIP133400930013793Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOTHYROXINE SODIQUEcomprimé | — | SA |
| LÉVOTHYROXINE SODIQUE ANHYDREcomprimé | 75 microgrammes · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.